This comes as the American College of Cardiology (ACC) released its five top trends in cardiovascular medicine in 2025, including Anti-Obesity Drugs: Cardiovascular Benefit Beyond Weight Loss. The ACC reports that semaglutide and tirzepatide both demonstrate remarkable cardiovascular benefits that extend beyond weight management. Clinical trials show these medications can reduce the risk of major adverse cardiovascular events by up to 20% in patients with obesity and preexisting cardiovascular conditions
Wegovy is specifically FDA-approved for chronic weight management in adults and adolescents aged 12 years and older with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia) [8] [9]
As GLP-1 drugs gain popularity, states are grappling with how to balance rising demand with budgetary constraints
In adult hermaphrodite germline, GLD-2 expression is low at the distal region, increases dramatically in the proximal region and oocytes, decreases during spermatogenesis and is excluded from mature sperm (Wang et al., 2002
All B vitamins are water-soluble, which means that any unused or excess amount present in the blood is excreted in the urine
These molecules are peptides or short chains of amino acids that form the building blocks of proteins
